Vivakor, Inc. is a biotechnology holding company with transdisciplinary research that focuses on developing and acquiring products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. They also provide contract research services for third parties.

The company is dedicated to advancing new ideas that improve life for the individual patient, researcher, clinician, and consumer. Vivakor’s business model is to be a research hub focused on areas that have both an identified scientific need and a substantial market opportunity.

From the commencement of product conception through development, the company targets specific commercialization strategies and expects to have collaborative partners or licensing arrangements in place for each of their products before completion. The company believes this model to offer several advantages to shareholders.

Let us hear your thoughts: Vivakor, Inc. Message Board

Last 5 posts by QualityStocks

• Wake Forest Bancshares, Inc. (WAKE) Reports Profitable Fiscal Year - November 25th, 2009
• Rahaxi, Inc. (RXHI.OB) Reports Increase in Hardware Revenue and a Reduction in Quarterly Loss - November 25th, 2009
• NuEarth Corp. (NUEC.PK) Offering Clean Technologies and Products to meet Rising Environmentally Friendly Chemicals Demand - November 25th, 2009
• According to Fed, Super-Low Rates Could Lead to a Speculative Bubble - November 25th, 2009
• Innovative Food Holdings, Inc. (IVFH.OB) Announces Record Sales for October – Management Comments on Third Quarter Results - November 25th, 2009